Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

NCT: NCT02998502 · TERMINATED

NCT IDNCT02998502
StatusTERMINATED
Start Date2016-09-01
Completion2021-01-30
SponsorJohns Hopkins University (OTHER)
First posted
Last updated

Brief Summary

This study will test the efficiency of the Freespira Breathing System in youth.

Frequently Asked Questions

What is The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens?

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens is a clinical trial registered under NCT02998502. Current status: TERMINATED.

What is the status of NCT02998502?

The current status of NCT02998502 (The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens) is: TERMINATED.

When did The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens start?

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens started on 2016-09-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.